New Data On Highly Effective Treatment For Chronic Rhinosinusitis Presented By OptiNose
OptiNose has announced important new results from a Phase II trial of its novel nasal drug delivery device with fluticasone for the treatment of chronic rhinosinusitis. Patients in the active treatment group experienced significant improvements in nasal symptoms, nasal discomfort and sense of smell. There was also a highly significant and progressive reduction in nasal swelling.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment